ContractAugust 9th, 2022
FiledAugust 9th, 2022CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII for Protocol CC-220-MM-002 pro Protokol CC-220-MM-002 This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tato Smlouva o klinické studii (dále „Smlouva”),byla uzavřena mezi těmito stranami: Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA represented for the purposes of this Agreement by Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux 1, 2017 Boudry, Switzerland (hereinafter the “Sponsor”)For the only purposes of signing this Agreement Sponsor is represented by PPD Investigator Services LLC, organized under the laws of the State of Delaware with its principal office at 929 North Front Street, Wilmington, North Carolina 28401, USA. Celgene Corporation s hlavním sídlem v 86 Morris Avenue, Summit, NJ 07901, USA zastupovaná pro účely této Smlouvy společností Celgene Intern